Showing results (141-150 of 322) with videos related to

Sort By:
Pageof 33
Research in Developmental Disabilities|October 16, 2012
Time perception in children treated for a cerebellar medulloblastomaSylvie Droit-Volet, Pierre S Zélanti, Georges Dellatolas, et al.
Frontiers in Medicine|March 13, 2023
Multimodal MRI radiomic models to predict genomic mutations in diffuse intrinsic pontine glioma with missing imaging modalitiesFahad Khalid, Jessica Goya-Outi, Thibault Escobar, et al.
Pediatric Blood & Cancer|June 1, 2005
Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumorsVirginie Kieffer-Renaux, Delphine Viguier, Marie-Anne Raquin, et al.
Pediatric Blood & Cancer|May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
Clinical Neuropathology|February 10, 2016
Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literatureAurore Siegfried, Anne Isabelle Bertozzi, Franck Bourdeaut, et al.
Journal of Neurosurgery|November 8, 2005
Preoperative chemotherapy in children with high-risk medulloblastomas: a feasibility studyJacques Grill, Arielle Lellouch-Tubiana, Selma Elouahdani, et al.
Pediatric Blood & Cancer|July 5, 2007
Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factorsStergios Zacharoulis, Lingyun Ji, Ian F Pollack, et al.
Pediatric Blood & Cancer|October 12, 2013
Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastomaFranck Bourdeaut, Catherine Miquel, Wilfrid Richer, et al.
Brain : a Journal of Neurology|December 13, 2002
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patientsJean-Sébastien Guillamo, Alain Créange, Chantal Kalifa, et al.
Pageof 33